Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Eli Lilly (LLY) files lawsuit against U.S. health agency over 340B Program rebates, alleging arbitrary blockage of its cash ...

Eli Lilly proposed a plan to ensure 340B entities pay no more than the ceiling price by providing them with cash directly on ...

Shares of several vaccine makers including Pfizer and Astrazeneca were down Friday morning following the nomination of Robert ...

Boston Pharmaceuticals has linked its metabolic dysfunction-associated steatohepatitis (MASH) prospect to improved outcomes ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...

By Samuel Indyk and Ludwig Burger (Reuters) -Shares in global vaccine makers and drugmakers fell on Friday after U.S.

Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain ...

Lilly filed a lawsuit Nov. 14 against HHS head Xavier Becerra and the Health Resources and Services Administration for blocking a plan to change its 340B program from immediate discounts to offering ...